• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1975年至2009年挪威低度和去分化骨肉瘤的临床流行病学

Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009.

作者信息

Berner Kjetil, Johannesen Tom Børge, Bruland Øyvind S

机构信息

Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, 0424 Oslo, Norway ; The Norwegian Cancer Registry, 0304 Oslo, Norway.

The Norwegian Cancer Registry, 0304 Oslo, Norway.

出版信息

Sarcoma. 2015;2015:917679. doi: 10.1155/2015/917679. Epub 2015 Aug 30.

DOI:10.1155/2015/917679
PMID:26412976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4568035/
Abstract

Purpose. To describe epidemiological, clinical characteristics and treatment outcomes of low-grade osteosarcoma (LGOS), including dedifferentiated osteosarcoma (DLGOS). Method. We analysed a nationwide cohort comprised of patients with histologically verified LGOS and DLGOS between 1975 and 2009, based on registry sources supplemented with clinical records from hospitals involved in sarcoma management. Results. Fifty-four patients were identified, 12 of whom had DLGOS. The annual incidence for all patients was 0.3 per million, with the peak incidence in the third decade of the life. Fifteen patients experienced local relapses during follow-up and ten developed metastatic diseases, including three at primary diagnosis. Patients with DLGOS dominated the metastatic relapse group. The five-year sarcoma-specific survival rate was 91%, with no documented improvement over time. Free margin following surgical resection of the primary tumour had a positive impact on survival. As expected, both local relapse and metastasis during follow-up were associated with an unfavourable outcome. Radiotherapy predicted poor survival due to the selection of high-risk patients in need of such treatment. Neither higher age nor axial tumour localisation was adverse prognostic factors. Conclusion. LGOS has an excellent prognosis when surgically resected with a free margin; however, LGOS has the potential to dedifferentiate and metastasize with a poor outcome.

摘要

目的。描述低级别骨肉瘤(LGOS)的流行病学、临床特征及治疗结果,包括去分化骨肉瘤(DLGOS)。方法。我们分析了一个全国性队列,该队列由1975年至2009年间组织学确诊的LGOS和DLGOS患者组成,数据来源于登记处,并补充了参与肉瘤管理的医院的临床记录。结果。共识别出54例患者,其中12例为DLGOS。所有患者的年发病率为百万分之0.3,发病高峰在生命的第三个十年。15例患者在随访期间出现局部复发,10例发生转移性疾病,其中3例在初次诊断时即出现转移。DLGOS患者在转移性复发组中占主导地位。五年肉瘤特异性生存率为91%,随时间推移无明显改善。原发肿瘤手术切除后的切缘阴性对生存有积极影响。正如预期的那样,随访期间的局部复发和转移均与不良预后相关。放疗预示着较差的生存率,因为接受此类治疗的是高危患者。较高年龄和轴向肿瘤定位均不是不良预后因素。结论。LGOS手术切除且切缘阴性时预后良好;然而,LGOS有去分化和转移的可能,预后较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5333/4568035/9e105368dfa6/SARCOMA2015-917679.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5333/4568035/4c0075a63954/SARCOMA2015-917679.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5333/4568035/9e105368dfa6/SARCOMA2015-917679.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5333/4568035/4c0075a63954/SARCOMA2015-917679.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5333/4568035/9e105368dfa6/SARCOMA2015-917679.002.jpg

相似文献

1
Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009.1975年至2009年挪威低度和去分化骨肉瘤的临床流行病学
Sarcoma. 2015;2015:917679. doi: 10.1155/2015/917679. Epub 2015 Aug 30.
2
Clinical epidemiology and treatment outcomes of spindle cell non-osteogenic bone sarcomas - A nationwide population-based study.梭形细胞非成骨性骨肉瘤的临床流行病学及治疗结果——一项基于全国人群的研究
J Bone Oncol. 2018 Nov 20;14:002-2. doi: 10.1016/j.jbo.2018.11.002. eCollection 2019 Feb.
3
Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.挪威高级别骨肉瘤的预后因素及治疗结果:超越“典型”患者的范畴
Sarcoma. 2015;2015:516843. doi: 10.1155/2015/516843. Epub 2015 Feb 17.
4
Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.1975年至2009年挪威的骨外骨肉瘤及文献简要综述
Anticancer Res. 2015 Apr;35(4):2129-40.
5
Surgically treated patients with axial and peripheral Ewing's sarcoma family of tumours: A population based study in Finland during 1990-2009.接受手术治疗的轴向和外周尤因肉瘤家族性肿瘤患者:1990 - 2009年芬兰的一项基于人群的研究。
Eur J Surg Oncol. 2015 Jul;41(7):893-8. doi: 10.1016/j.ejso.2015.02.010. Epub 2015 Mar 19.
6
Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.恶性原发性骨脊柱肿瘤患者的生存率:来自 1973 年至 2003 年监测、流行病学和最终结果(SEER)数据库的结果。
J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.
7
[Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].[去分化软骨肉瘤。13例临床病例研究及文献复习]
Rev Chir Orthop Reparatrice Appar Mot. 1994;80(8):669-80.
8
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
9
Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.腹膜后肉瘤的辅助放疗。斯堪的纳维亚肉瘤研究组对97例患者的研究。
Acta Oncol. 2014 Sep;53(9):1165-72. doi: 10.3109/0284186X.2014.921723. Epub 2014 Jul 7.
10
Incidence, epidemiology and treatment results of osteosarcoma in Finland - a nationwide population-based study.芬兰骨肉瘤的发病率、流行病学和治疗结果:一项基于全国人口的研究。
Acta Oncol. 2011 Nov;50(8):1206-14. doi: 10.3109/0284186X.2011.615339.

引用本文的文献

1
Dedifferentiated parosteal osteosarcoma with a novel low-grade leiomyosarcomatous and high-grade conventional osteosarcomatous differentiation: Case report and review of literature.具有新型低级别平滑肌肉瘤样和高级别传统骨肉瘤样分化的去分化骨旁骨肉瘤:病例报告及文献复习
Int J Surg Case Rep. 2024 Dec;125:110570. doi: 10.1016/j.ijscr.2024.110570. Epub 2024 Nov 8.
2
Limb Salvage Surgery in a Rare Case of Recurrent Parosteal Osteosarcoma with Vascular Graft Thrombosis.复发性骨膜外骨肉瘤伴血管移植血栓形成罕见病例的保肢手术
Vasc Specialist Int. 2023 Nov 6;39:33. doi: 10.5758/vsi.230058.
3
Synchronous Primary Parosteal Osteosarcoma and Primary Mediastinal Germ Cell Tumour with Atypical Mycobacterial Infection - A Rare Phenomenon: A Case Report.

本文引用的文献

1
Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.1975年至2009年挪威的骨外骨肉瘤及文献简要综述
Anticancer Res. 2015 Apr;35(4):2129-40.
2
Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.挪威高级别骨肉瘤的预后因素及治疗结果:超越“典型”患者的范畴
Sarcoma. 2015;2015:516843. doi: 10.1155/2015/516843. Epub 2015 Feb 17.
3
Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
同步性原发性骨膜骨肉瘤与原发性纵隔生殖细胞肿瘤合并非典型分枝杆菌感染——一种罕见现象:病例报告
Malays Orthop J. 2023 Mar;17(1):188-192. doi: 10.5704/MOJ.2303.023.
4
Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs ().犬特发性动脉病、附肢骨梗死和骨梗死的肿瘤性转化在 108 只狗中()。
Comp Med. 2022 Oct 1;72(5):306-319. doi: 10.30802/AALAS-CM-22-000037. Epub 2022 Sep 16.
5
Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study.低度恶性骨肉瘤的去分化:日本肌肉骨骼肿瘤学组(JMOG)研究。
Int J Clin Oncol. 2022 Nov;27(11):1758-1766. doi: 10.1007/s10147-022-02223-8. Epub 2022 Aug 6.
6
LINC00662 Long Non-Coding RNA Knockdown Attenuates the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Regulating the microRNA-15a-5p/Notch2 Axis.LINC00662长链非编码RNA敲低通过调控微小RNA-15a-5p/Notch2轴减弱骨肉瘤细胞的增殖、迁移和侵袭
Onco Targets Ther. 2020 Aug 10;13:7517-7530. doi: 10.2147/OTT.S256464. eCollection 2020.
7
Parosteal Osteosarcoma: A Benign-Looking Tumour, Amenable to a Variety of Surgical Reconstruction.骨旁骨肉瘤:一种看似良性的肿瘤,适合多种手术重建方式。
Int J Surg Oncol. 2020 May 28;2020:4807612. doi: 10.1155/2020/4807612. eCollection 2020.
8
Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.鉴定和验证一个有效的多 miRNA 标志物,用于预测骨肉瘤患者的预后。
Med Sci Monit. 2020 Feb 26;26:e919272. doi: 10.12659/MSM.919272.
9
MicroRNA-451 dictates the anoikis resistance of osteosarcoma by targeting Rab14.微小RNA-451通过靶向Rab14决定骨肉瘤的失巢凋亡抗性。
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10989-10997. eCollection 2017.
10
Long non-coding RNA XIST predicts poor prognosis and promotes malignant phenotypes in osteosarcoma.长链非编码RNA XIST预测骨肉瘤预后不良并促进其恶性表型。
Oncol Lett. 2019 Jan;17(1):256-262. doi: 10.3892/ol.2018.9596. Epub 2018 Oct 18.
全国范围内未经选择的骨肉瘤患者队列中发病率和生存率的时间趋势。
Acta Oncol. 2015 Jan;54(1):25-33. doi: 10.3109/0284186X.2014.923934. Epub 2014 Jun 24.
4
Parosteal osteosarcoma.骨旁骨肉瘤。
Arch Pathol Lab Med. 2014 May;138(5):694-9. doi: 10.5858/arpa.2013-0030-RS.
5
Osteosarcoma treatment - where do we stand? A state of the art review.骨肉瘤治疗——我们处于什么位置?最新综述。
Cancer Treat Rev. 2014 May;40(4):523-32. doi: 10.1016/j.ctrv.2013.11.006. Epub 2013 Nov 27.
6
Low-grade central osteosarcoma: a difficult condition to diagnose.低级别中央型骨肉瘤:一种难以诊断的病症。
Sarcoma. 2012;2012:764796. doi: 10.1155/2012/764796. Epub 2012 Jul 16.
7
Central low-grade osteosarcoma: a diagnostic challenge.中央型低级别骨肉瘤:一项诊断挑战。
Skeletal Radiol. 2012 Apr;41(4):365-7. doi: 10.1007/s00256-012-1359-8. Epub 2012 Feb 7.
8
Incidence, epidemiology and treatment results of osteosarcoma in Finland - a nationwide population-based study.芬兰骨肉瘤的发病率、流行病学和治疗结果:一项基于全国人口的研究。
Acta Oncol. 2011 Nov;50(8):1206-14. doi: 10.3109/0284186X.2011.615339.
9
Incidence and survival of malignant bone sarcomas in England 1979-2007.1979-2007 年英格兰恶性骨肉瘤的发病率和存活率。
Int J Cancer. 2012 Aug 15;131(4):E508-17. doi: 10.1002/ijc.26426. Epub 2011 Nov 2.
10
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?骨肉瘤的化学辅助治疗:我们处于什么位置?
Eur J Cancer. 2011 Nov;47(16):2431-45. doi: 10.1016/j.ejca.2011.05.030. Epub 2011 Jun 22.